Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy

Ado-trastuzumab emtansine (T-DM1) is an antibody–drug conjugate consisting of the monoclonal antibody trastuzumab linked to the maytansinoid DM1 with potential antineoplastic activity and is approved for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. An analysis of the US Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakroush, Samy, Wulf, Svenja, Gallwas, Julia, Tampe, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667226/
https://www.ncbi.nlm.nih.gov/pubmed/34912725
http://dx.doi.org/10.3389/fonc.2021.796223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667226/
https://www.ncbi.nlm.nih.gov/pubmed/34912725
http://dx.doi.org/10.3389/fonc.2021.796223

Ejemplares similares